You have 9 free searches left this month | for more free features.

Overall Status

Recruiting (2)

Sign in for free

Phase

phase 1/phase 2 (2)

Sponsor

NextCure, Inc. (2)

Collaborator

Merck Sharp & Dohme LLC (1)

Intervention

nc410 (2)

pembrolizumab (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Industry (2)

Study Type

Interventional (2)

nc410

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Advanced or Metastatic Solid Tumors, Ovarian Cancer, Gastric Cancer Trial in United States (NC410)

Recruiting

Advanced or Metastatic Solid Tumors
+3 more

NC410

Bethesda, Maryland
+4 more

May 25, 2022

Advanced or Metastatic Solid Tumors, Microsatellite Instability Low, Microsatellite Instability High Trial in United States

Recruiting

Advanced or Metastatic Solid Tumors
+11 more

NC410
Pembrolizumab

Tucson, Arizona
+11 more

Dec 2, 2022